Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$247K Sell
9,773
-5,974
-38% -$141K 0.02% 509
2026
Q1
$344K Sell
15,747
-6,010
-28% -$139K 0.03% 410
2025
Q4
$506K Buy
21,757
+1,030
+5% +$24.8K 0.04% 312
2025
Q3
$587K Buy
20,727
+1,879
+10% +$49.9K 0.04% 293
2025
Q2
$414K Buy
18,848
+234
+1% +$5.12K 0.03% 332
2025
Q1
$434K Sell
18,614
-52
-0.3% -$1.33K 0.04% 305
2024
Q4
$536K Buy
18,666
+632
+4% +$18.9K 0.05% 279
2024
Q3
$535K Buy
18,034
+2,630
+17% +$81.7K 0.05% 271
2024
Q2
$519K Buy
+15,404
New +$532K 0.05% 261
2020
Q3
Sell
-17,074
Closed -$440K 336
2020
Q2
$440K Buy
17,074
+20
+0.1% +$501 0.1% 194
2020
Q1
$378K Buy
17,054
+415
+2% +$11.5K 0.1% 184
2019
Q4
$482K Sell
16,639
-715
-4% -$20.1K 0.1% 180
2019
Q3
$478K Buy
17,354
+387
+2% +$10.2K 0.11% 176
2019
Q2
$418K Sell
16,967
-119
-0.7% -$2.69K 0.09% 209
2019
Q1
$353K Buy
17,086
+2,017
+13% +$42.2K 0.08% 223
2018
Q4
$305K Buy
+15,069
New +$316K 0.08% 226

Other funds holding GNTX

Smith, Moore & Co's GNTX Position: Q2 2026 in Review

Smith, Moore & Co reduced its Gentex (GNTX) stake by 38% in Q2 2026, selling an estimated $141K and leaving 9,773 shares worth $247K. The position accounts for 0.02% of the portfolio, ranked #509.

Smith, Moore & Co first reported a position in GNTX in Q4 2018 and has held it in 16 quarters since. The position peaked at $587K in Q3 2025. 531 funds tracked by Wall St. Rank hold GNTX as of Q2 2026.

  • Smith, Moore & Co held 9,773 shares of Gentex worth $247K as of Q2 2026.
  • Smith, Moore & Co sold 5,974 Gentex shares in Q2 2026, an estimated $141K.
  • Gentex made up 0.02% of Smith, Moore & Co's portfolio in Q2 2026, its #509 holding.
  • Smith, Moore & Co first reported a position in Gentex in Q4 2018 and has held it in 16 quarters since.
  • Smith, Moore & Co's Gentex position peaked at $587K in Q3 2025.
  • 531 funds tracked by Wall St. Rank held Gentex as of Q2 2026.

Based on Smith, Moore & Co's 13F filing for Q2 2026, filed 12 Aug 2026.